Cardiac complications in Duchenne muscular dystrophy (DMD) are the result of cardiac muscle involvement that accompanies the ...

Pathologic changes of the X-chromosome gene for dystrophin give rise to Duchenne muscular dystrophy (DMD), and dystrophin -- ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

People with certain mutations in the gene coding for dysferlin develop muscular dystrophy—a group of muscle wasting diseases that affect thousands around the world. Professor Simone Spuler and ...

More than 30 types of muscular dystrophy have been identified. They all cause problems with movement due to genetic mutations that lead to the inadequate production of proteins that your muscles need.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, shared the following ...

An abnormality in the DMD gene causes Duchenne muscular dystrophy. The DMD gene produces dystrophin, a protein that maintains the structure of muscle cells. People with DMD have mutations (changes ...

CureDuchenne is investing $1 million in Entos Pharmaceuticals to support the development of a new DMD gene therapy.

What Is Duchenne Muscular Dystrophy ... For the small number of DMD patients with a gene mutation that can be treated by skipping exon 45 (a certain section of genetic code), doctors can ...

and different mutations affect muscles in different ways. The Muscular Dystrophy Association currently recognizes 33 different types of CMD. Each type involves a specific genetic mutation.

A new gene therapy for Duchenne muscular dystrophy (DMD ... could be applied to other genetic diseases that are caused by mutations in large genes. The research was published in the journal ...